The mechanism through which it promotes fat loss, primarily beta-3 adrenergic receptor activation, is completely separate from IGF-1 signaling
Doctors prescribe them to treat diabetes only when lifestyle interventions and other medications (like metformin) fail to control blood sugar
Our team then takes over insurance verification and prior authorization, submitting requests to your insurance provider to eliminate the hassle for you
1 The gap between Mounjaro and Rybelsus for weight loss and blood sugar control is likely even larger
Of course, prolonged water fasting is not a suitable treatment option for all patients with obesity
Ambery P, Parker VE, Sumvoll M et al (2018) MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomized, controlled, double-blind, ascending dose and phase 2A study